Developing strategies to target lncRNAs are needed. In this chapter, we describe in detail a method to deliver antisense oligonucleotides into acute myeloid leukemia cells using lipid nanoparticles tagged with the transferrin receptor. While this chapter is focused on the delivery method, we also discuss important considerations about the design of antisense oligonucleotides (ASOs). The strategy described here has been used successfully to deliver ASOs into leukemic blasts and stem cells.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/978-1-0716-1581-2_11 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!